These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 324069)

  • 21. Biochemical derangements in ischemic myocardium: the role of carnitine.
    Siliprandi N; Di Lisa F; Toninello A
    G Ital Cardiol; 1984 Oct; 14(10):804-8. PubMed ID: 6240423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
    Tune BM; Hsu CY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine acyltransferases and their influence on CoA pools in health and disease.
    Ramsay RR; Zammit VA
    Mol Aspects Med; 2004; 25(5-6):475-93. PubMed ID: 15363637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carnitine acylcarnitine translocase deficiency].
    Kimura M; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():714-6. PubMed ID: 12013981
    [No Abstract]   [Full Text] [Related]  

  • 25. Inherited disorders of mitochondrial fatty acid oxidation.
    Coates PM; Stanley CA
    Prog Liver Dis; 1992; 10():123-38. PubMed ID: 1296227
    [No Abstract]   [Full Text] [Related]  

  • 26. Assays of fatty acid beta-oxidation activity.
    Bennett MJ
    Methods Cell Biol; 2007; 80():179-97. PubMed ID: 17445695
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of carnitine in intermediary metabolism].
    Thomitzek WD
    Ergeb Physiol; 1970; 62():68-90. PubMed ID: 4911144
    [No Abstract]   [Full Text] [Related]  

  • 28. [The influence of carnitine on the oxidation of fatty acids in mitochondria].
    Zborowski J
    Postepy Biochem; 1966; 12(4):563-75. PubMed ID: 5336237
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergic and complementary effects of L-carnitine and coenzyme Q on long-chain fatty acid metabolism and on protection against anthracycline damage.
    Conte A; Palmieri L; Ronca G; Giovannini L; Bertelli A
    Int J Tissue React; 1990; 12(3):197-201. PubMed ID: 2276901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited cardiomyopathies.
    Kelly DP; Strauss AW
    N Engl J Med; 1994 Mar; 330(13):913-9. PubMed ID: 8114864
    [No Abstract]   [Full Text] [Related]  

  • 31. Transport and function of carnitine: relevance to carnitine-deficient diseases.
    Siliprandi N
    Ann N Y Acad Sci; 1986; 488():118-26. PubMed ID: 3555251
    [No Abstract]   [Full Text] [Related]  

  • 32. Carnitine and the twins.
    Bressler R
    N Engl J Med; 1970 Mar; 282(13):745-6. PubMed ID: 5416207
    [No Abstract]   [Full Text] [Related]  

  • 33. Carnitine metabolism in human subjects. III. Metabolism in disease.
    Mitchell ME
    Am J Clin Nutr; 1978 Apr; 31(4):645-59. PubMed ID: 416708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular energy metabolism during fetal development. VI. Fatty acid oxidation by developing brain.
    Warshaw JB; Terry ML
    Dev Biol; 1976 Aug; 52(1):161-6. PubMed ID: 183994
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary plasmalemmal carnitine transporter defect manifested with dicarboxylic aciduria and impaired fatty acid oxidation.
    Tang NL; Hui J; Law LK; To KF; Ruiter JP; IJlst L; Wanders RJ; Ho CS; Fok TF; Yuen PM; Hjelm NM
    J Inherit Metab Dis; 1998 Jun; 21(4):423-5. PubMed ID: 9700600
    [No Abstract]   [Full Text] [Related]  

  • 36. An hypothesis concerning the role of carnitine in the control of interrelations between fatty acid and carbohydrate metabolism.
    Fritz IB
    Perspect Biol Med; 1967; 10(4):643-77. PubMed ID: 6034906
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatty acid peroxide formation in tissue homogenates from mice with hereditary myopathy (dystrophia muscularis).
    BAKER N; BLOOM A; BLAHD WH
    Am J Physiol; 1959 Aug; 197():483-6. PubMed ID: 13796020
    [No Abstract]   [Full Text] [Related]  

  • 38. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.
    York B; Reineke EL; Sagen JV; Nikolai BC; Zhou S; Louet JF; Chopra AR; Chen X; Reed G; Noebels J; Adesina AM; Yu H; Wong LJ; Tsimelzon A; Hilsenbeck S; Stevens RD; Wenner BR; Ilkayeva O; Xu J; Newgard CB; O'Malley BW
    Cell Metab; 2012 May; 15(5):752-63. PubMed ID: 22560224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoenzymes: general considerations and alterations in human and animal myopathies.
    Pearson CM; Kar NC
    Ann N Y Acad Sci; 1966 Sep; 138(1):293-303. PubMed ID: 5230210
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis.
    Brivet M; Slama A; Ogier H; Boutron A; Demaugre F; Saudubray JM; Lemonnier A
    J Inherit Metab Dis; 1994; 17(3):271-4. PubMed ID: 7807931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.